Stock summary: bluebird bio reported 44.11% plunge as the company is set to be taken over
The bluebird bio Inc stock closed at 4.08 USD, experiencing a sharp decline of 3.22 USD (-44.11%) over the past five days.
Stay updated with the latest news and articles about bluebird bio.
The bluebird bio Inc stock closed at 4.08 USD, experiencing a sharp decline of 3.22 USD (-44.11%) over the past five days.
In first place was Aspire Biopharma Holdings, Inc. which dropped -51.46%, trading at 2.99 USD, with its market capitalization positioned at 47.83M USD.
At the top of the chart was Aspire Biopharma Holdings, Inc. fell 44.48%, trading at 3.42 USD, with a market capitalization of 26.56 million USD.
In first place, Nuburu, Inc. surged 81.61%, reaching 0.3634 USD, with a market capitalization of 7.37 million USD.